Downstream Signaling Pathways in Mouse Adipose Tissues Following Acute In Vivo Administration of Fibroblast Growth Factor 21
Authors:
Open Access
- 6 September 2013
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (9) , e73011
Abstract
FGF21 is a novel secreted protein with robust anti-diabetic, anti-obesity, and anti-atherogenic activities in preclinical species. In the current study, we investigated the signal transduction pathways downstream of FGF21 following acute administration of the growth factor to mice. Focusing on adipose tissues, we identified FGF21-mediated downstream signaling events and target engagement biomarkers. Specifically, RNA profiling of adipose tissues and phosphoproteomic profiling of adipocytes, following FGF21 treatment revealed several specific changes in gene expression and post-translational modifications, specifically phosphorylation, in several relevant proteins. Affymetrix microarray analysis of white adipose tissues isolated from both C57BL/6 (fed either regular chow or HFD) and db/db mice identified over 150 robust potential RNA transcripts and over 50 potential secreted proteins that were changed greater than 1.5 fold by FGF21 acutely. Phosphoprofiling analysis identified over 130 phosphoproteins that were modulated greater than 1.5 fold by FGF21 in 3T3-L1 adipocytes. Bioinformatic analysis of the combined gene and phosphoprotein profiling data identified a number of known metabolic pathways such as glucose uptake, insulin receptor signaling, Erk/Mapk signaling cascades, and lipid metabolism. Moreover, a number of novel events with hitherto unknown links to FGF21 signaling were observed at both the transcription and protein phosphorylation levels following treatment. We conclude that such a combined "omics" approach can be used not only to identify robust biomarkers for novel therapeutics but can also enhance our understanding of downstream signaling pathways; in the example presented here, novel FGF21-mediated signaling events in adipose tissue have been revealed that warrant further investigation.Keywords
This publication has 37 references indexed in Scilit:
- An FGF21-Adiponectin-Ceramide Axis Controls Energy Expenditure and Insulin Action in MiceCell Metabolism, 2013
- Increased Responses to the Actions of Fibroblast Growth Factor 21 on Energy Balance and Body Weight in a Seasonal Model of AdiposityJournal of Neuroendocrinology, 2012
- βKlotho Is Required for Fibroblast Growth Factor 21 Effects on Growth and MetabolismCell Metabolism, 2012
- Fibroblast Growth Factor-21 Regulates PPARγ Activity and the Antidiabetic Actions of ThiazolidinedionesCell, 2012
- Acute glucose-lowering and insulin-sensitizing action of FGF21 in insulin-resistant mouse models—association with liver and adipose tissue effectsAmerican Journal of Physiology-Endocrinology and Metabolism, 2009
- Overexpression of Sprouty 2 in Mouse Lung Epithelium Inhibits Urethane-Induced TumorigenesisAmerican Journal of Respiratory Cell and Molecular Biology, 2009
- Tissue-specific Expression of βKlotho and Fibroblast Growth Factor (FGF) Receptor Isoforms Determines Metabolic Activity of FGF19 and FGF21Journal of Biological Chemistry, 2007
- The Metabolic State of Diabetic Monkeys Is Regulated by Fibroblast Growth Factor-21Endocrinology, 2007
- Role of the Fatty Acid Binding Protein mal1 in Obesity and Insulin ResistanceDiabetes, 2003
- Negative regulation of peroxisome proliferator-activated receptor-gamma gene expression contributes to the antiadipogenic effects of tumor necrosis factor-alpha.Molecular Endocrinology, 1996